EPHA2 and gastric cancer: In gastric carcinoma, erythropoietin producing hepatocellular (EphA2), a receptor tyrosine kinase (RTK) is found to be over expressed in 77.3% of gastric cancer patients [260,264,266,284] and plays a vital role in metastasis via regulation of MMP-9 gene expression.